Somrita Basu

Dr. Somrita Basu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YJYiru Jin
Yiru Jin
SBSomrita Basu
Somrita Basu
MFMei Feng
Mei Feng
YNYu Ning
Yu Ning
IMIndeewara Munasinghe
Indeewara Munasinghe
MWMichael Zhuo Wang
Michael Zhuo Wang
Visceral leishmaniasis is a life-threatening parasitic disease, but current antileishmanial drugs have severe drawbacks. Antifungal azoles inhibit the activity of cytochrome P450 (CYP) 51 enzymes which are responsible for removing the C14α-methyl group of lanosterol, a key step in ergosterol biosynthesis in Leishmania. However, they exhibit varying degrees of antileishmanial activities in culture, suggesting the existence of unrecognized molecular targets. Our previous study reveals that, in Leishmania, lanosterol undergoes parallel C4- and C14-demethylation to form 4α,14α-dimethylzymosterol and T-MAS, respectively. In the current study, CYP5122A1 is identified as a sterol C4-methyl oxidase that catalyzes the sequential oxidation of lanosterol to form C4-oxidation metabolites. CYP5122A1 is essential for both L. donovani promastigotes in culture and intracellular amastigotes in infected mice. CYP5122A1 overexpression results in growth delay, increased tolerance to stress, and altered expression of lipophosphoglycan and proteophosphoglycan. CYP5122A1 also helps to determine the antileishmanial effect of antifungal azoles in vitro. Dual inhibitors of CYP51 and CYP5122A1 possess superior antileishmanial activity against L. donovani promastigotes whereas CYP51-selective inhibitors have little effect on promastigote growth. Our findings uncover the critical biochemical and biological role of CYP5122A1 in L. donovani and provide an important foundation for developing new antileishmanial drugs by targeting both CYP enzymes.

Verified
Journal Article
Open access
PDF file
YNYu Ning
Yu Ning
SBSomrita Basu
Somrita Basu
FHFONG HSU
FONG HSU
MFMei Feng
Mei Feng
MWMichael Zhuo Wang
Michael Zhuo Wang
KZKai Zhang
Kai Zhang
Sterol biosynthesis requires the oxidative removal of two methyl groups from the C-4 position by sterol C-4-demethylase and one methyl group from the C-14 position by sterol C-14-demethylase. In Leishmania donovani, a CYP5122A1 (Cytochrome P450 family 5122A1) protein was recently identified as the bona fide sterol C-4 methyl oxidase catalyzing the initial steps of C-4-demethylation. Besides CYP5122A1, Leishmania parasites possess orthologs to ERG25 (ergosterol pathway gene 25), the canonical sterol C-4 methyl oxidase in Saccharomyces cerevisiae. To determine the contribution of CYP5122A1 and ERG25 in sterol biosynthesis, we assessed the essentiality of these genes in Leishmania major, which causes cutaneous leishmaniasis. Like in L. donovani, CYP5122A1 in L. major could only be deleted in the presence of a complementing episome. Even with strong negative selection, L. major chromosomal CYP5122A1-null mutants retained the complementing episome in both promastigote and amastigote stages, demonstrating its essentiality. In contrast, the L. major ERG25-null mutants were fully viable and replicative in culture and virulent in mice. Deletion and overexpression of ERG25 did not affect the sterol composition, indicating that ERG25 is not required for C-4-demethylation. These findings suggest that CYP5122A1 is the dominant and possibly only sterol C-4 methyl oxidase in Leishmania, and inhibitors of CYP5122A1 may have strong therapeutic potential against multiple Leishmania species.

2 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
YNYu Ning
Yu Ning
SBSomrita Basu
Somrita Basu
FHFONG HSU
FONG HSU
MFMei Feng
Mei Feng
MWMichael Zhuo Wang
Michael Zhuo Wang
KZKai Zhang
Kai Zhang
Background: Despite progress in access to family planning services in many sub-Saharan 11 African countries in recent decades, advances in early postpartum contraceptive adoption remain 12 low, and the unmet need for early postpartum contraceptives is high. According to the Ethiopia 13 Demographic and Health Survey report, early postpartum modern contraceptive method uptake is 14 still unacceptably low in Ethiopia. Objectives: This study aimed to determine the magnitude of 15 intention to adoption of early postpartum modern contraceptive methods and its associated factors 16 among pregnant women in Dessie and Kombolcha town zones, northeast Ethiopia. Methods: A 17 community-based cross-sectional study was deployed from January 15–February 15, 2023, in the 18 Dessie and Kombolcha zones, north-east Ethiopia among pregnant women. The study involved 780 19 pregnant women using the cluster sampling technique. A census was conducted in 20 randomly 20 selected clusters to identify eligible pregnant women. Actual data were collected home-to-home in 21 the community through face-to-face interviews. Data were collected by Open Data Kit (ODK) and 22 exported to STATA 17 for analysis. A multivariable logistic regression analysis was done and the 23 goodness of the model was checked by Hosmer-Lemeshow's test statistic and rock curve. An ad- 24 justed odds ratio with a 95% confidence interval and P-value < 0.05 was considered statistically sig- 25 nificant. Result: The study revealed that 49.6% of pregnant women lack autonomy and 50% lack 26 knowledge about early postpartum contraception, with participants' wealth index status ranging 27 from rich (36.6%) to poor (33.2%). The study found that 75.8% of pregnant women intended to adopt 28 early postpartum modern contraceptive methods early after childbirth. After controlling the poten- 29 tial confounder’s mothers age (AOR = 6.2 [2.6–14.6], birth interval (AOR = 2.5 [1.6–3.7]), have paid 30 work (AOR = 1.9 [1.3–2.8]), health facility from home (AOR=2.6[1.5-4.4]), last delivery 31 Place(AOR=2.4[1.1-5.7]), knowledge on (AOR = 1.5 [1.1-2.1]), and antenatal care follow-up (AOR = 32 1.9 [1.2-3.3]) were significant associated factors of intention to uptake early postpartum modern con- 33 traceptive methods among pregnant women. Conclusion: The study found that 75% of the partici- 34 pants had the intention to adoption of contraceptive methods during the early postpartum period. 35 Identified factors influencing this intention were age, birth interval, women's employment status, 36 area of residence, distance to health facilities, last delivery place, knowledge of early postpartum 37 modern contraception, gravidity, and antenatal care follow-up. These findings highlight the need 38 for targeted interventions to address these factors, framing the intended users and enabling access 39 to early adoption of postpartum contraceptive methods.